Case report
2026
[Aplastic anemia developed after treatment with durvalumab].
This case highlights the importance of considering AA in the differential diagnosis of persistent thrombocytopenia or pancytopenia during immune checkpoint inhibitor therapy, and reports of AA induced by durvalumab are extremely limited.
K. Maeshima, Yoshiko Sakayori, Hiroki Yokoyama et al.
· [Rinsho ketsueki] The Japane... · 0 citations